全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Follicular Dendritic Cell-Specific Prion Protein (PrPc) Expression Alone Is Sufficient to Sustain Prion Infection in the Spleen

DOI: 10.1371/journal.ppat.1002402

Full-Text   Cite this paper   Add to My Lib

Abstract:

Prion diseases are characterised by the accumulation of PrPSc, an abnormally folded isoform of the cellular prion protein (PrPC), in affected tissues. Following peripheral exposure high levels of prion-specific PrPSc accumulate first upon follicular dendritic cells (FDC) in lymphoid tissues before spreading to the CNS. Expression of PrPC is mandatory for cells to sustain prion infection and FDC appear to express high levels. However, whether FDC actively replicate prions or simply acquire them from other infected cells is uncertain. In the attempts to-date to establish the role of FDC in prion pathogenesis it was not possible to dissociate the Prnp expression of FDC from that of the nervous system and all other non-haematopoietic lineages. This is important as FDC may simply acquire prions after synthesis by other infected cells. To establish the role of FDC in prion pathogenesis transgenic mice were created in which PrPC expression was specifically “switched on” or “off” only on FDC. We show that PrPC-expression only on FDC is sufficient to sustain prion replication in the spleen. Furthermore, prion replication is blocked in the spleen when PrPC-expression is specifically ablated only on FDC. These data definitively demonstrate that FDC are the essential sites of prion replication in lymphoid tissues. The demonstration that Prnp-ablation only on FDC blocked splenic prion accumulation without apparent consequences for FDC status represents a novel opportunity to prevent neuroinvasion by modulation of PrPC expression on FDC.

References

[1]  Mabbott NA, Young J, McConnell I, Bruce ME (2003) Follicular dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility. J Virol 77: 6845–6854.
[2]  Prinz M, Huber G, Macpherson AJS, Heppner FL, Glatzel M, et al. (2003) Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes. Am J Pathol 162: 1103–1111.
[3]  Horiuchi M, Furuoka H, Kitamura N, Shinagawa M (2006) Alymphoplasia mice are resistant to prion infection via oral route. Jap J Vet Res 53: 149–157.
[4]  Glaysher BR, Mabbott NA (2007) Role of the GALT in scrapie agent neuroinvasion from the intestine. J Immunol 178: 3757–3766.
[5]  Andreoletti O, Berthon P, Marc D, Sarradin P, Grosclaude J, et al. (2000) Early accumulation of PrPSc in gut-associated lymphoid and nervous tissues of susceptible sheep from a Romanov flock with natural scrapie. J Gen Virol 81: 3115–3126.
[6]  Sigurdson CJ, Williams ES, Miller MW, Spraker TR, O'Rourke KI, et al. (1999) Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J Gen Viroly 80: 2757–2764.
[7]  Hilton D, Fathers E, Edwards P, Ironside J, Zajicek J (1998) Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352: 703–704.
[8]  Wilke G, Steinhauser G, Grun J, Berek C (2010) In silico subtraction approach reveals a close lineage relationship between follicular dendritic cells and BP3hi stromal cells isolated from SCID mice. Eur J Immunol 40: 2165–2173.
[9]  Beekes M, McBride PA (2007) The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies. FEBS J 274: 588–605.
[10]  Bolton DC, McKinley MP, Prusiner SB (1982) Identification of a protein that purifies with the scrapie prion. Science 218: 1309–1311.
[11]  Legname G, Baskakov IV, Nguyen H-OB, Riesner D, Cohen FE, et al. (2004) Synthetic mammalian prions. Science 305: 673–676.
[12]  Manson JC, Clarke AR, Hooper ML, Aitchison L, McConnell I, et al. (1994) 129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol 8: 121–127.
[13]  Brown KL, Stewart K, Ritchie D, Mabbott NA, Williams A, et al. (1999) Scrapie replication in lymphoid tissues depends on PrP-expressing follicular dendritic cells. Nat Med 5: 1308–1312.
[14]  Klein MA, Frigg R, Raeber AJ, Flechsig E, Hegyi I, et al. (1998) PrP expression in B lymphocytes is not required for prion neuroinvasion. Nat Med 4: 1429–1433.
[15]  Klein MA, Kaeser PS, Schwarz P, Weyd H, Xenarios I, et al. (2001) Complement facilitates early prion pathogenesis. Nat Med 7: 488–492.
[16]  Mabbott NA, Bruce ME, Botto M, Walport MJ, Pepys MB (2001) Temporary depletion of complement component C3 or genetic deficiency of C1q significantly delays onset of scrapie. Nat Med 7: 485–487.
[17]  Mabbott NA, Bruce ME (2004) Complement component C5 is not involved in scrapie pathogenesis. Immunobiology 209: 545–549.
[18]  Zabel MD, Heikenwalder M, Prinz M, Arrighi I, Schwarz P, et al. (2007) Stromal complement receptor CD21/35 facilitates lymphoid prion colonization and pathogenesis. J Immunol 179: 6144–6152.
[19]  Denzer K, Kleijmeer MJ, Heijnen HFG, Stoorvogel W, Geuze HJ (2000) Exosome: from internal vesicle of the multivesicular body to intercellular signalling device. J Cell Sci 113: 3365–3374.
[20]  Fevrier B, Vilette D, Archer F, Loew D, Faigle W, et al. (2004) Cells release prions in association with exosomes. Proc Natl Acad Sci USA 101: 9683–9688.
[21]  Denzer K, van Eijk M, Kleijmeer MJ, Jakobson E, de Groot C, et al. (2000) Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol 165: 1259–1265.
[22]  Mohan J, Brown KL, Farquhar CF, Bruce ME, Mabbott NA (2004) Scrapie transmission following exposure through the skin is dependent on follicular dendritic cells in lymphoid tissues. J Dermatol Sci 35: 101–111.
[23]  Heikenwalder M, Kurrer MO, Margalith I, Kranich J, Zeller N, et al. (2008) Lymphotoxin-dependent prion replication in inflammatory stromal cells of granulomas. Immunity 29: 998–1008.
[24]  Thomzig A, Kratzel C, Lenz G, Krüger D, Beekes M (2003) Widespread PrPSc accumulation in muscles of hamsters orally infected with scrapie. EMBO Rep 4: 530–533.
[25]  ?imák J, Holanda K, D'Agnillo F, Janota J, Vostal JG (2002) Cellular prion protein in expressed on endothelial cells and is released during apoptosis on membrane microparticles found in human plasma. Transfusion 42: 334–342.
[26]  Kraus M, Alimzhanov MB, Rajewsky N, Rajewsky K (2004) Survival of resting mature B lymphocytes depends on BCR signaling via the Igα/β heterodimer. Cell 117: 787–800.
[27]  Victoratos P, Lagnel J, Tzima S, Alimzhanov MB, Rajewsky K, et al. (2006) FDC-specific functions of p55TNFR and IKK2 in the development of FDC networks and of antibody responses. Immunity 24: 65–77.
[28]  Mao X, Fujiwara Y, Orkin SH (1999) Improved reporter strain for monitoring Cre recombinase-mediated DNA excisions in mice. Proc Natl Acad Sci, USA 96: 5037–5042.
[29]  Tkachuk M, Bolliger S, Ryffel B, Pluschke G, Banks TA, et al. (1998) Crucial role of tumour necrosis factor receptor 1 expression on nonhematopoietic cells for B cell localization within the splenic white pulp. J Exp Med 187: 469–477.
[30]  Schmidt-Supprian M, Rajewsky K (2007) Vagaries of conditional gene targeting. Nat Immunol 8: 665–668.
[31]  Tuzi NL, Clarke AR, Bradford B, Aitchison L, Thomson V, et al. (2004) Cre-loxP mediated control of PrP to study transmissible spongiform encephalopathy diseases. Genesis 40: 1–6.
[32]  Taylor PR, Pickering MC, Kosco-Vilbois MH, Walport MJ, Botto M, et al. (2002) The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues. Eur J Immunol 32: 1883–1896.
[33]  Glatzel M, Heppner FL, Albers KM, Aguzzi A (2001) Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31: 25–34.
[34]  Schulz-Schaeffer WJ, Tschoke S, Kranefuss N, Drose W, Hause-Reitner D, et al. (2000) The paraffin-embedded tissue blot detects PrPsc early in the incubation time in prion diseases. Am J Pathol 156: 51–56.
[35]  Mabbott NA, Mackay F, Minns F, Bruce ME (2000) Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nat Med 6: 719–720.
[36]  Raymond CR, Aucouturier P, Mabbott NA (2007) In vivo depletion of CD11c+ cells impairs scrapie agent neuroinvasion from the intestine. J Immunol 179: 7758–7766.
[37]  Brown KL, Wathne GJ, Sales J, Bruce ME, Mabbott NA (2009) The effects of host age on follicular dendritic cell status dramatically impair scrapie agent neuroinvasion in aged mice. J Immunol 183: 5199–5207.
[38]  Fu Y-X, Molina H, Matsumoto M, Huang G, Min J, et al. (1997) Lymphotoxin-α (LTα) supports development of splenic follicular structure that is required for IgG response. J Exp Med 185: 2111–2120.
[39]  Fu Y-X, Huang G, Wang Y, Chaplin DD (1998) B lymphocytes induce the formation of follicular dendritic cell clusters in a lymphotoxin α-dependent fashion. J Exp Med 187: 1009–1018.
[40]  Endres R, Alimzhanov MB, Plitz T, Futterer A, Kosco-Vilbois MH, et al. (1999) Mature follicular dendritic cell networks depend on expression of lymphotoxin β receptor by radioresistant stromal cells and of lymphotoxin β and tumour necrosis factor by B cells. J Exp Med 189: 159–168.
[41]  Fu Y-X, Huang G, Wang Y, Chaplin DD (2000) Lymphotoxin-α-dependent spleen microenvironment supports the generation of memory B cells and is required for their subsequent antigen-induced activation. J Immunol 164: 2508–2514.
[42]  Aydar Y, Sukumar A, Szakal AK, Tew JG (2005) The influence of immune complex-bearing follicular dendritic cells on the IgM response, Ig class switching, and production of high affinity IgG. J Immunol 174: 5358–5366.
[43]  Manson JC, Clarke AR, McBride PA, McConnell I, Hope J (1994) PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3: 331–340.
[44]  Mabbott NA, Williams A, Farquhar CF, Pasparakis M, Kollias G, et al. (2000) Tumor necrosis factor-alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J Virol 74: 3338–3344.
[45]  Prinz M, Montrasio F, Klein MA, Schwarz P, Priller J, et al. (2002) Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc Natl Acad Sci USA 99: 919–924.
[46]  Montrasio F, Frigg R, Glatzel M, Klein MA, Mackay F, et al. (2000) Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288: 1257–1259.
[47]  Shortman K, Liu Y-J (2002) Mouse and human dendritic cell subtypes. Nat Rev Immunol 2: 151–161.
[48]  Imazeki N, Senoo A, Fuse Y (1992) Is the Follicular Dendritic Cell a Primarily Stationary Cell? Immunology 76: 508–510.
[49]  Mabbott NA, Bailie JK, Kobayashi A, Donaldson DS, Ohmori H, et al. (2011) Expression of mesenchyme-specific gene signatures by follicular dendritic cells: insights from the meta-analysis of microarray data from multiple mouse cell populations. Immunology 133: 482–498.
[50]  Mandel TE, Phipps RP, Abbot A, Tew JG (1980) The follicular dendritic cell: long term antigen retention during immunity. Immunol Review 53: 29–59.
[51]  Suzuki K, Grigorova I, Phan TG, Kelly LM, Cyster JG (2009) Visualizing B cell capture of cognate antigen from follicular dendritic cells. J Exp Med 206: 1485–1493.
[52]  Kranich J, Krautler NJ, Heinen E, Polymenidou M, Bridel C, et al. (2008) Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8. J Exp Med 205: 1293–1302.
[53]  Burton GF, Brandon FK, Estes JD, Thacker TC, Gartner S (2002) Follicular dendritic cell contributions to HIV pathogenesis. Sem Immunol 14: 275–284.
[54]  Gommerman JL, Browning JL (2003) Lymphotoxin/LIGHT, lymphoid microenvironments and autoimmune disease. Nat Rev Immunol 3: 642–654.
[55]  Kapasi ZF, Qin D, Kerr WG, Kosco-Vilbois MH, Schultz LD, et al. (1998) Follicular dendritic cell (FDC) precursors in primary lymphoid tissues. J Immunol 160: 1078–1084.
[56]  Hanamaya R, Tanaka M, Miyasaka K, Aozasa K, Koike M, et al. (2004) Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304: 1147–1150.
[57]  Mackay F, Browning JL (1998) Turning off follicular dendritic cells. Nature 395: 26–27.
[58]  McGovern G, Mabbott NA, Jeffrey M (2009) Scrapie affects the maturation cycle and immune complex trapping by follicular dendritic cells in mice. PLoS One 4: e8186.
[59]  Carp RI, Callahan SM (1982) Effect of mouse peritoneal macrophages on scrapie infectivity during extended in vitro incubation. Intervirology 17: 201–207.
[60]  Maignien T, Shakweh M, Calvo P, Marcé D, Salès N, et al. (2005) Role of gut macrophages in mice orally contaminated with scrapie or BSE. Int J Pharmaceutics 298: 293–304.
[61]  Crozet C, Lezmi S, Flamant F, Samarut J, Baron T, et al. (2007) Peripheral circulation of the prion infectious agent in transgenic mice expressing the ovine prion protein in neurons only. J Infect Dis 195: 997–1006.
[62]  Mohan J, Bruce ME, Mabbott NA (2005) Follicular dendritic cell dedifferentiation reduces scrapie susceptibility following inoculation via the skin. Immunology 114: 225–234.
[63]  Fischer M, Rulicke T, Raeber A, Sailer A, Moser M, et al. (1996) Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie. EMBO J 15: 1255–1264.
[64]  Fraser H, Dickinson AG (1973) Agent-strain differences in the distribution and intensity of grey matter vacuolation. J Comp Pathol 83: 29–40.
[65]  Fraser H, Dickinson AG (1968) The sequential development of the brain lesions of scrapie in three strains of mice. J Comp Pathol 78: 301–311.
[66]  Farquhar CF, Somerville RA, Ritchie LA (1989) Post-mortem immunodiagnosis of scrapie and bovine spongiform encephalopathy. J Virol Met 24: 215–222.
[67]  McBride P, Eikelenboom P, Kraal G, Fraser H, Bruce ME (1992) PrP protein is associated with follicular dendritic cells of spleens and lymph nodes in uninfected and scrapie-infected mice. J Pathol 168: 413–418.
[68]  Inman CF, Rees LEN, Barker E, Haverson K, Stokes CR, et al. (2005) Validation of computer-assisted, pixel-based analysis of multiple-colour immunofluorescence histology. J Immunoll Met 302: 156–167.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133